# ynBiome

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ynbiome

- Industry: Biotechnology
- Headquarters: Hangzhou, China
- Latest round: Angel (Apr 19, 2023)
- Investors on record: 3

## About

Established in 2022 and based in Hangzhou, China, ynBiome is a biotechnology company that focuses on providing integrated microbial engineering solutions. The company's founder and chief scientist, Dr. Lei Dai, graduated from MIT and returned to China in 2018 to join the Shenzhen Institute of Advanced Sciences of the Chinese Academy of Sciences as a doctoral supervisor and director of the Synthetic Microbiome Center. In April 2023, it raised angel funding led by new investor Heda Venture, with participation from other new investors Woyong Fund and Yayi Capital.

The company is committed to building a data-driven microbiome engineering platform by integrating artificial intelligence and synthetic biology technologies to develop functional microorganisms and bioactive substances that promote the health of crops, animals, and humans, and provide innovative products and solutions for agriculture, carbon neutrality, and health.

## Funding rounds

- Angel, Apr 19, 2023 — Heda Venture, Woyong Fund, Yael Capital

## Investors

- Heda Venture (https://capitalatlas.ai/funds/heda-venture) — Angel
- Woyong Fund — Angel
- Yael Capital (https://capitalatlas.ai/funds/yael-capital) — Angel